These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6984022)

  • 1. Thymus independence of hybrid resistance against a panel of T-cell lymphomas of H-2b origin.
    Klein GO; Kärre K; Kiessling R; Klein G
    Int J Cancer; 1982 Nov; 30(5):659-62. PubMed ID: 6984022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanism.
    Grönberg A; Klein GO; Kärre K; Kiessling R; Klein G
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):183-90. PubMed ID: 7201394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytotoxic effector mechanism and genetic control of non-immunized hybrid resistance to mouse T cell lymphoma transplanted outside and inside the brain].
    Yamasaki T; Kikuchi H; Ljunggren HG; Kärre K; Klein G
    Neurol Med Chir (Tokyo); 1990; 30(11 Spec No):800-5. PubMed ID: 1709455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
    Serreze DV; Leiter EH
    J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
    Ljunggren HG; Kärre K
    J Exp Med; 1985 Dec; 162(6):1745-59. PubMed ID: 3877776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid resistance to EL-4 lymphoma cells. II. Association between loss of hybrid resistance and detection of suppressor cells after treatment of mice with 89Sr.
    Leuvano E; Kumar V; Bennett M
    Scand J Immunol; 1981; 13(6):563-71. PubMed ID: 6458878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.
    Daley JP; Nakamura I
    J Exp Med; 1984 Apr; 159(4):1132-48. PubMed ID: 6368735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of B cell lymphomas derived from thymectomized AKR mice expressing TL.4 antigen.
    Peled A; Haran-Ghera N
    J Exp Med; 1985 Sep; 162(3):1081-6. PubMed ID: 3897447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
    Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
    No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.
    Bosco N; Swee LK; Bénard A; Ceredig R; Rolink A
    Exp Hematol; 2010 Mar; 38(3):222-232.e2. PubMed ID: 20045443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
    Kärre K; Klein GO; Kiessling R; Klein G
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed phenotype lymphomas in thymectomized (SL/KhxAKR/Ms)F1 mice.
    Lu LM; Hiai H
    Jpn J Cancer Res; 1999 Nov; 90(11):1218-23. PubMed ID: 10622532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-T-cell resistance against a mouse Moloney lymphoma.
    Kiessling R; Petrányi G; Klein G; Wigzell H
    Int J Cancer; 1976 Feb; 17(2):275-81. PubMed ID: 1082449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?
    Zinkernagel RM; Callahan GN; Althage A; Cooper S; Klein PA; Klein J
    J Exp Med; 1978 Mar; 147(3):882-96. PubMed ID: 305459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of phenotypically distinct NK1.1+ T cells upon antigen expression in the thymus or in the liver.
    Legendre V; Boyer C; Guerder S; Arnold B; Hämmerling G; Schmitt-Verhulst AM
    Eur J Immunol; 1999 Jul; 29(7):2330-43. PubMed ID: 10427996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
    Milisauskas VK; Nakamura I
    J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic differences in F1 hybrid resistance against tumours of the same parental strain. I. Tumours of C57Bl/6 origin.
    Klein GO; Klein G
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):731-42. PubMed ID: 6800800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.